🔗 Share this article

A shadow economy for unapproved slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are urged to contact these accounts directly for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with thousands of members share comparison images, administration instructions and assertions of rapid UK delivery. Vendors market the drug there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Concerns

However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in users injecting substances of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or prison.

Service Reaction and Content Removal

According to the social media company, the platform has taken down violative content and prohibited associated hashtags and search suggestions. The company stated it was dedicated to maintaining the service secure and investing in enhancing compliance measures.

Digital Marketplace Operations

Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, filled with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at residence.

Within moments of entering one group, a vendor posted contact information, where most transactions occur. The seller sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Product Details and Pricing

Inside these communities, messages show black plastic parcels with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service stated it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.

Her staff has already encountered individuals harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to possibly significant health risks”.